Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -18.076% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. COc1ccc(NC(=O)CSc2ccc3nnc(-c4ccccn4)n3n2)cc1OC
b. Cc1ccc(-c2nc(SCC(=O)c3c(N)n(C)c(=O)n(C)c3=O)n[nH]2)cc1
Answer: a. COc1ccc(NC(=O)CSc2ccc3nnc(-c4ccccn4)n3n2)cc1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(NC(=O)CSc2ccc3nnc(-c4ccccn4)n3n2)cc1OC
COc1ccc(NC(=O)CSc2ccc3nnc(-c4ccccn4)n3n2)cc1OC
N-(3,4-dimethoxyphenyl)-2-[(3-pyridin-2-yl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)sulfanyl]acetamide